Abstract
As seen in Chapter 6, both the number and value of biotechnology-related business deals between Japan and the United States are significant, and roughly comparable with those between the United States and Western Europe. For U.S. companies interested in either initiating or expanding their international business, there are two obvious choices, the EEC and Japan. Japan is generally considered a more difficult and laborious choice but it is important as a market, and as a source of both investment and technology.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Copyright information
© 1990 Robert T. Yuan and Mark D. Dibner
About this chapter
Cite this chapter
Yuan, R.T., Dibner, M.D. (1990). Doing Business in Japan. In: Japanese Biotechnology. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-11762-8_8
Download citation
DOI: https://doi.org/10.1007/978-1-349-11762-8_8
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-11764-2
Online ISBN: 978-1-349-11762-8
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)